Abstract
Central nervous system (CNS) regulation of anterior pituitary function involves the interaction of two major bodily systems — the nervous and endocrine systems. A discussion of both the role of the CNS in hormonal regulation and of hormonal effects on CNS function is outside the scope of this chapter, which will focus mainly on selected aspects of the role of the CNS in hormonal regulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F. H. A. Marshall, Sexual periodicity and the causes which determine it, Phil. Trans B226:423–456 (1936).
G. W. Harris, The induction of ovulation in the rabbit by electrical stimulation of the hypothalamo-hypophyseal mechanism, Proc. Roy. Soc. Lond. Ser. B 122:374–394 (1937).
J. DeGroot and G. W. Harris, Hypothalamic control of the anterior pituitary gland and blood lymphocytes, J. Physiol 111:335–346 (1950).
R. Burgus and R. Guillemin, Hypothalamic releasing factors, Ann. Rev. Biochem 39:499–526 (1970).
J. Meites, “Hypothalamic Hormones of the Hypophysis,” Williams Wilkins, Baltimore (1970).
B. Donovan, “Mammalian Neuroendocrinology,” McGraw-Hill, New York, (1970).
S. M. McCann and J. C Porter, Hypothalamic-pituitary stimulating and inhibiting hormones, Physiol. Rev 49:240–284 (1969).
L. Martini and W. F. Ganong, “Neuroendocrinology,” Vols. I and II, Academic Press, New York and London (1966).
G. W. Harris and B. T. Donovan, “The Pituitary Gland,” University of California Press, Berkeley and Los Angeles (1966).
S. Reichlin, J. B. Martin, M. Mitnick, R. L. Boshans, V. Grimm, J. Bollinger, J. Gordon, and J. Malacars, The hypothalamus in pituitary-thyroid regulation, Rec. Progr. Hormone Res 28:229–286 (1972).
B. Halasz, L. Pupp, and S. Uhlarin, Hypophysiotropic area in the hypothalamus, J. Endocrinol 25:147–15(1962).
L. Krulich, P. Illner, C. P. Fawcett, M. Quijada, and S. M. McCann, in “Growth and Growth Hormone” (I. A. Pecile and E. Muller, eds.) pp. 306–316, Excerpta Medica, Amsterdam (1972).
R. Guillemin, E. Sakiz, and D. N. Ward, Further purification of TSH releasing factor (TRF) from sheep hypothalamic tissues, with observations on the amino acid composition, Proc. Soc. Exptl. Biol. Med 118:1132–1137 (1965).
K. M. Knigge and D. E. Scott, Structure and function of the median eminence, Am. J. Anat 129:223–244 (1970).
H. Kobayashi and T. Matsui, in “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) pp. 3–46, Oxford University Press, New York (1969).
B. Folck and C. Owman, A detailed methodological description of the fluorescence method for the cellular demonstration of biogenic amines, Acta Univ. Lond. Sect. II 7:1–23 (1965).
R. S. Piezzi, F. Larin, and R. J. Wurtman, Serotonin, 5-hydroxyindoleacetic acid (5HIAA) and monoamine oxidase in the bovine median eminence and pituitary gland, Endocrinology 86:1460–1462 (1970).
G. B. Wislocki and L. S. King, The permeability of the hypophysis and hypothalamus to vital dyes with a study of the hypophyseal vascular supply, Am. J. Anat 58:421–472 (1936).
J. C. Porter, I. A. Kamberi, and Y. A. Grazia, in “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) pp. 145–177, Oxford University Press, New York (1971).
A. V. Schally, T. W. Redding, J. F. Barrett, and C. Y. Bowers, Purification of porcine thyrotropin releasing factor (TRF), Fed. Proc 25:348 (1966).
R. Burgus, T. F. Dunn, D. Desiderio, and R. Guillemin, Derives polypeptididiques de synthese doues d’activite hypophysiotrope TRF nouvelles observations, Compt. Rend. Acad. Sci 269:1870–1873 (1969).
K. Folkers, F. Enzmann, J. Boler, C. Y. Bowers, and A. V. Schally, Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity, Biochem. Biophys. Res. Commun 37:123–126 (1969).
R. Burgus, T. F. Dunn, D. Desiderio, D. N. Ward, W. Vale, R. Guillemin, A. M. Felix, D. Gillessen, and R. C. Studes, Biological activity of synthetic Polypeptide derivatives related to the structure of hypothalamic TRF, Endocrinology 86:573–589 (1970).
J. Boler, F. Enzmann, K. Folkers, C. Y. Bowers, and A. V. Schally, The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline-amide. Biochem. Biophys. Res. Commun 37:705–710 (1969).
J. A. Pittman, Jr., E. D. Haigler, Jr., J. M. Hershman, and C. S. Pittman, Hypothalamic hypothyroidism, New Engl. J. Med 284:844–845 (1971).
N. Fleischer, M. Lorente, J. Kirkland, R. Kirkland, G. Clayton, and M. Calderon, Increased secretion of prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man, J. Clin. Endocrinol 34:617–624 (1972).
W. Vale, R. Burgus, and R. Guillemin, Competition between thyroxine and TRF at the pituitary level in release of TSH, Proc. Soc. Exptl. Biol. Med 125:210–213 (1967).
C. Y. Bowers, A. V. Schally, G. A. Reynolds, and W. D. Hawley, Interactions of l-thyroxine or l-triiodothyronine and thyrotropin-releasing factor on the release and synthesis of thyrotropin from the anterior pituitary gland of mice, Endocrinology 81:741–747 (1967).
C. Y. Bowers, K. L. Lee, and A. V. Schally, A study on the interaction of the thyrotropinreleasing factor and l-triiodothyronin: Effects of puromycin and cyclohexamide, Endocrinology 82:75–82 (1968).
W. Vale, R. Burgus, and R. Guillemin, On the mechanism of action of TRF: Effects of cycloheximide and actinomycin on the release of TSH stimulated in vitro by TRF and its inhibition by thyroxine, Neuroendocrinology 3:34–46 (1968).
J. P. Wilber and R D. Utiger, The effect of glucocorticoids on thyrotropin secretion, J. Clin. Invest 48:2096–2103 (1969).
L. S. Jacobs, P. J. Snyder, J. F. Wilber, R. D. Utiger, and W. H. Daughaday, Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man, J. Clin. Endocrinol 33:996–998 (1971).
C. Y. Bowers, H. G. Friesen, P. Hwang, H. J. Guyda, and K. Folkers, Prolactin and thyrotropin release in man by synthetic pyroglytamyl-histidyl-prolinamide, Biochem. Biophys. Res. Commun 45:1033–1041 (1971).
A. Arimura and A. V. Schally, Progesterone suppression of LH releasing hormoneinduced stimulation of LH release in rats, Endocrinology 87:653–657 (1970).
A. Arimura and A. V. Schally, Augmentation of pituitary responsiveness to LH-releasing hormone (LH-RH) by estrogen, Proc. Soc. Exptl. Biol. Med 136:290–293 (1971).
V. Hillard, A. V. Schally, and C. H. Sawyer, Progesterone blockade of the ovulatory response to intrapituitary infusion of LH-RH in rats, Endocrinology 88:730–736 (1971).
A. V. Schally, A. Arimura, Y. Baba, R. M. G. Nair, H. Matsuo, T. W. Redding, and L. Debeljuk, Isolation and properties of the FSH and LH-releasing hormone, Biochem. Biophys. Res. Commun 43:393–399 (1971).
H. Matsuo, Y. Baba, R. M. G. Nair, A. Arimura, and A. V. Schally, Structure of the porcine LH-and FSH-releasing hormone in the proposed amino acid sequence, Biochem. Biophys. Res. Commun 43:1334–1339 (1971).
S. S. C. Yen, R. Rebar, G. Vandenberg, and H. Judd, Hypothalamic amenorrhea and hypogonadotropism: Responses to synthetic LRH, New Engl. J. Med (in press).
R. M. G. Nair, A. J. Kastin, and A. V. Schally, Isolation and structure of hypothalamic MSH release-inhibiting hormone, Biochem. Biophys. Res. Commun 43:1376–1381 (1971).
M. E. Celis, S. Taleisnik, I. L. Schwartz, and R. Walter, Proposed structure of melanocyte stimulating hormone release inhibitory factor, Biophys. Soc. Abst 11:98a (1971).
A. P. Dhariwal, C. E. Grosvenor, J. Antunes-Rodrigues, and S. M. McCann, Studies on the purification of ovine prolactin-inhibing factor, Endocrinology 82:1236–1241 (1968).
A. V. Schally, Y. Baba, and R. M. G. Nair, The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus, J. Biol. Chem 246:6647–6650 (1971).
A. J. Kastin, A. V. Schally, C. Gual, S. Glick, and A. Arimura, Clinical evaluation in man of a substance with growth hormone releasing activity in rats, J. Clin. Endocrinol 35:326–329 (1972).
L. A. Frohman, J. W. Maran, and A. P. S. Dhariwal, Plasma growth hormone responses to intrapituitary injections of growth hormone releasing factor (GRF) in the rat, Endocrinology 88:1483–1488 (1971).
D. F. Veber, R. D. Bennett, J. D. Milkowski, G. Gal, R. G. Denkewalter, and R. Hirschmann, Synthesis of a proposed growth hormone releasing factor, Biochem. Biophys. Res. Commun 45:235–239 (1971).
A. P. S. Dhariwal, L. Krulich, and S. M. McCann, Purification of a growth hormoneinhibitory factor (GIF) from sheep hypothalamus, Neuroendocrinology 4:282–288 (1969).
A. V. Schally, S. Sawano, A. Arimua, J. F. Barrett, I. Wakabayashi, and C. Y. Bowers, Isolation of growth hormone-releasing hormone (GRH) from porcine hypothalami, Endocrinology 84:1493–1506 (1969).
R. Guillemin, Hypothalamic factors releasing pituitary hormones, Rec. Progr. Hormone Res 20:89–121 (1964).
E. Scharrer and B. Scharrer, “Neuroendocrinology,” Columbia University Press, New York (1963).
I. I. Geschwind, in “Hypophysiotropic Hormones of the Hypothalamus” (J. Meites, ed.) pp. 298–319, Williams and Wilkins, Baltimore (1970).
B. S. McEwen, J. M. Weiss, and L. Schwartz, Uptake of corticosterone by rat brain and its concentration by certain limbic structures, Brain Res 6:227–241 (1969).
J. L. Gerlach and B. S. McEwen, Rat brain binds adrenal steroid hormone — Radioautography of hippocampus with corticosterone, Science 175:1133–1136 (1972).
W. E. Stumpf, Estradiol-concentrating neurons: Topography in the hypothalamus by dry-mount autoradiography, Science 159:1001–1003 (1968).
H. P. Krieger and D. T. Krieger, Chemical Stimulation of the brain: Effect on adrenal corticoid release, Am. J. Physiol 218:1632–1641 (1970).
N. E. Miller, Chemical coding of behavior in the brain, Science 148:328–338 (1965).
W. G. Blackard and S. A. Heidingsfelder, Adrenergic receptor control mechanism for growth hormone secretion, J. Clin. Invest 47:1407–1414 (1968).
C. Lucke and S. M. Glick, Experimental modification of the sleep induced peak of growth hormone secretion, J. Clin. Endocrinol 32:729–736 (1971).
Y. Takahashi, D. M. Kipnis, and W. H. Daughaday, Growth hormone secretion during sleep, J. Clin. Invest 47:2079–2090 (1968).
A. E. Boyd, III, H. E. Levobitz, and J. B. Pfeiffer, Stimulation of human growth hormone secretion by l-DOPA, New Engl. J. Med 283:1425–1429 (1970).
P. C. Kansal, J. Buse, O. R. Talbert, and M. G. Buse, The effect of l-DOPA on plasma growth hormone, insulin and thyroxine, J. Clin. Endocrinol 34:99–105 (1972).
P. T. K. Toivolia and C. C. Gale, Stimulation of growth hormone release by microinjection of norepinephrine into hypothalamus of baboons, Endocrinology 90:895–902 (1972).
W. G. Blackard and C. C. Waddell, Cholinergic blockade and growth hormone responsiveness to insulin hypoglycemia, Proc. Soc. Exptl. Biol. Med 131:192–196 (1969).
H. P. G. Schneider and S. M. McCann, Mono-and indolamines and control of LH secretion, Endocrinology 86:1127–1133 (1970).
I. A. Kamberi, R. S. Mical, and J. C. Porter, Effect of anterior pituitary perfusion and intraventricular injection of catecholamines and indoleamines on LH release, Endocrinology 87:1–12 (1970).
I. A. Kamberi, R. S. Mical, and J. C. Porter, Effect of anterior pituitary perfusion and intraventricular injection of catecholamines on prolactin release, Endocrinology 88:1012–1020 (1971).
C. Kordon and J. Glowinski, Selective inhibition of superovulation by blockade of dopamine synthesis during the “critical period” in the immature rat, Endocrinology 85: 924–931 (1969).
K. H. Lu, Y. Amenomori, C. L. Chen, and J. Meites, Effects of central acting drugs on serum and pituitary prolactin levels in rats, Endocrinology 87:667–672 (1970).
R. W. Turkington and J. H. Mclndoe, Stimulation of human prolactin secretion by intravenous infusion of l-tryptophan, Am. Soc. Clin. Invest, p. 98a (1972) (abst.).
J. W. Everett, C. H. Sawyer, and J. E. Markee, A neurogenic timing factor in control of the ovulatory discharge of luteinizing hormone in the cyclic rat, Endocrinology 44:234–250 (1949).
D. T. Krieger, A. I. Silverberg, F. Rizzo, and H. P. Krieger, Abolition of circadian periodicity of plasma 17-OHCS levels in the cat, Am. J. Physiol 215:959–967 (1968).
D. T. Krieger and F. Rizzo, Circadian periodicity of plasma 17-OHCS: Mediation by serotonin dependent pathways, Am. J. Physiol 217:1703–1707 (1969).
G. R. VanLoon, W. Nicholson, and R. Brown, Drug-induced hypersecretion of ACTH in rats and its treatment with l-DOPA, in “Fifty-third Meeting of the Endocrine Society,” San Francisco, p. A-129 (1971). (abst.).
E. V. Naumenko, Hypothalamic chemoreactive structures and the regulation of pituitaryadrenal function, Brain Res 11:1–10 (1968).
E. Endroczi, G. Schreiberg, and K. Lissak, The role of central nervous activating and inhibitory structures in the control of pituitary-adrenocortical function. Effects of intracerebral cholinergic and adrenergic stimulation, Acta. Physiol. Acad. Sci. Hung 24:211–221 (1963).
G. R. VanLoon, L. Hilger, A. B. King, A. T. Boryczka, and W. F. Ganong, Inhibitory effect of L-dihydroxyphenylalanine on the adrenal venous 17-hydroxycorticosteroid response to surgical stress in dogs, Endocrinology 88:1404–1414 (1971).
G. R. VanLoon, U. Scapagnini, G. P. Moberg, and W. F. Ganong, Evidence for central adrenergic neural inhibition of ACTH secretion in the rat, Endocrinology 89:1464–1469 (1971).
G. A. Hedge and P. G. Smelik, Corticotropin release: Inhibition by intrahypothalamic implantation of atropine, Science 159:891–892 (1968).
K. Fuxe, H. Corrodi, T. Hokfelt, and G. Jonsson, Central monoamine neurons and pituitary-adrenal activity, Progs. Brain Res 32:42–56 (1970).
P. G. Smelik, ACTH secretion after depletion of hypothalamic monoamines by reserpine implants, Neuroendocrinology 2:247–254 (1967).
E. M. Bogdanove, Direct gonad-pituitary feedback: An analysis of effects of intracranial estrogenic depots on gonadotropin secretion, Endocrinology 73:696–712 (1963).
J. W. Kendall, in “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) pp. 177–207, Oxford University Press, New York 1969).
S. Reichlin, in “Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) Vol. 1, pp. 445–536, Academic Press, New York (1967).
R. L. Van deWiele, J. Bogumil, I. Dyrenfurth, M. Ferin, R. Jewelewicz, M. Warren, and G. M. Khali, Mechanisms regulating the menstrual cycle in women, Rec. Progr. Hormone Res 26:63–94 (1970).
E. E. Muller, S. Sawano. A. Arimura, and A. V. Schally, Mechanism of action of growth hormone altering its own secretion rate: Comparison with the action of dexamethasone, Acta Endocrinol 56:499–509 (1967).
M. Motta, F. Fraschini, F. Piva, and L. Martini, in “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) pp. 211–253, Oxford University Press, New York (1969).
F. E. Yates, in “The Adrenal Cortex.” (A. B. Eisenstein, ed.) pp. 133–183, Little Brown, Boston (1967).
B. Bohus, C. Nyakas, and K. Lissak, Involvement of suprahypothalamic structures in the hormonal feedback of corticosteroids, Acta Physiol. Hung 34:1–8 (1968).
B. Donovan, in “Mammalian Endocrinology,” p. 71, McGraw-Hill, New York (1970).
D. M. Woodbury and A. Vernadakis, in “Methods in Hormone Research” (R. I. Dorfman ed.) Vol. 5, pp. 1–57, Academic Press, New York (1966).
K. Ruf and F. A. Steiner, Steroid sensitive single neurons in rat hypothalamus and midbrain; identification by microelectrophoresis, Science 156:667–669 (1967).
C. H. Sawyer, M. Kawakami, B. Myerson, D. J. Whitmayer, and J. J. Lilley, Effects of ACTH, dexamethasone and asphyxia on electrical activity of rat hypothalamus, Brain Res 10:213–226 (1968).
A. R. Green and G. Curzon, Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol, Nature 22:1095–1097 (1968).
S. Blanco, D. S. Schalch, and S. Reichlin, Control of growth hormone secretion by glucoreceptors in the hypothalamic-pituitary unit. Fed. Proc 25:191 (1966).
L. Krulich and S. M. McCann, Influence of stress on the growth hormone content of the pituitary of the rat, Proc. Soc. Exptl. Biol. Med 121:1114–1119 (1966).
B. Flerko and J. Szentagothai, Oestrogen sensitive nervous structures in the hypothalamus, Acta Endocrinol 26:121–127 (1957).
J. Szentagothai, B. Flerko, B. Mess, and B. Halasz, “Hypothalamic Control of the Anterior Pituitary,” pp. 192–265, Publ. House Hung. Acad. Sci, Budapest (1962).
D. W. Pfaff, Uptake of 3H-estradiol by the female rat brain. An autoradiographic study, Endocrinology 82:1149–1155 (1968).
V. D. Ramirez, B. R. Komisaruk, D. I. Whitmayer, and C. H. Sawyer, Effects of hormones and vaginal stimulation on the EEG and hypothalamic units in rats, Am. J. Physiol 212: 1376–1384 (1967).
Y. Palka, V. D. Ramirez, and C. H. Sawyer, Distribution and biological effects of tritiated estradiol implanted in the hypothalamo-hypophyseal region of female rats, Endocrinology 78:487–499 (1966).
J. Davidson, in “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.) pp. 343–388, Oxford University Press, New York (1969).
M. Igarashi, Y. Ibuki, H. Kubu, J. Kumioka, N. Yokota, Y. Ebara, and S. Matsumoto, Mode and site of action of clomiphene, Am. J. Obstet. Gynecol 97:120–123 (1967).
S. Kannematsu and C. H. Sawyer, Blockade of ovulation in rabbits by hypothalamic implants of norethindrone, Endocrinology 76:691–699 (1965).
K. Seiki, M. Miyamota, A. Yamashita, and M. Kotani, Further studies on the uptake of labelled progesterone by the hypothalamus and pituitary of rats, J. Endocrinol 43:129–130(1969).
C. H. Sawyer, M. Kawakami, and S. Kannematsu, Neuroendocrine aspects of reproduction, Proc. Assc. Res. Nerv. Ment. Dis 43:59–84 (1966).
B. S. McEwen, D. W. Pfaff, and R. E. Zigmond, Factors influencing sex hormone uptake by rat brain regions. III. Effects of competing steroids on testosterone uptake, Brain Res 21:29–38(1970).
S. Reichlin, in “Neuroendocrinology” (L. Martini and W. Ganong, eds.) Vol. I, pp. 445–536, Academic Press, New York (1966).
K. M. Knigge, in “Major Problems in Neuroendocrinology” (E. Bajusz and G. Jasmin, eds.) pp. 261–285, Karger, Basel (1964).
J. W. Kendall, S. I. Shimoda, and M. Greer, Brain dependent TSH secretion from heterotopic pituitaries, Neuroendocrinology 2:76–87 (1967).
H. Halberg, Chronobiology, Ann. Rev. Physiol 31:675–725 (1969).
J. Aschoff, Exogenous and endogenous components in circadian rhythms, Cold Spring Harbor Symp. Quant. Biol 25:11–28 (1960).
J. Benoit, The role of the eye and of the hypothalamus in the photostimulation of gonads in the dark, Ann. N.Y. Acad. Sci 117:204–216 (1964).
W. F. Ganong, M. D. Shepherd, J. R. Wall, E. T. Van Brunt, and M. T. Clegg, Penetration of light into the brain of mammals, Endocrinology 72:962–963 (1963).
V. Critchlow, in “Advances in Neuroendocrinology” (A. Nalbandov, ed.) pp. 377–402, University of Illinois Press, Urbana, Ill. (1963).
R. Y. Moore, A. Heller, R. K. Bhatnager, R. J. Wurtman, and J. Axelrod, Central control of the pineal gland — Visual pathways, Arch. Neurol 18:208–218 (1968).
L. G. Wesson, Jr., Electrolyte excretion in relation to diurnal cycles of renal function, Medicine 43:547–592 (1964).
D. T. Krieger, J. Kreuzer, and F. Rizzo, Constant light: Effect on circadian pattern and phase reversal of steroid and electrolyte levels in man, J. Clin. Endocrinol 29:1634–1638 (1969).
R. Franks, Diurnal variation of plasma 17-OHCS in children, J. Clin. Endocrinol 27:75–78 (1967).
D. J. Reis, A. Corvelli, and J. Conners, Circadian and ultradian rhythms of serotonin regionally in cat brain, J. Pharmacol. Exptl. Therap 167:328–333 (1969).
F. Hery, E. Rouer, and J. Glowinski, Daily variations of serotonin metabolism in the rat brain, Brain Res 43:445–465 (1972).
C. J. Migeon, F. H. Tyler, J. P. Mahoney, A. A. Florentin, H. Castle, E. K. Bliss, and L. T. Samuels, The diurnal variation of plasma levels and urinary excretion of 17-hydroxycorticosteroids in normal subjects, night workers and blind subjects in man, J. Clin. Endocrinol 16:622–633 (1956).
G. T. Perkoff, K. Eik-Nes, C. A. Nugent, H. L. Fred, R. A. Nimer, L. Rush, L. T. Samuels, and F. H. Tyler, Studies of the diurnal variation of plasma 17-hydroxycorticosteroids, J. Clin. Endocrinol 16:432–443 (1959).
D. T. Krieger, W. Allen, F. Rizzo, and H. P. Krieger, Characterization of the normal pattern of plasma corticosteroid levels, J. Clin. Endocrinol 32:266–284 (1971).
C. T. Nichols and F. H. Tyler, Diurnal variation in adrenal cortical function, Ann. Rev. Med 18:313–324 (1967).
K. Takebe, M. Sakakura, and K Mashimo, Continuance of diurnal rhythmicity of CRF activity in hypophysectomized rats, Endocrinology 90:1515–1520 (1972).
T. Hiroshige and M. Sakakura, Circadian rhythm of corticotropin releasing activity in the hypothalamus of normal and adrenalectomized rats, Neuroendocrinology 7:25–36 (1971).
G. Seiden and A. Brodish, Presence of a diurnal rhythm in hypothalamic corticotrophin releasing factor (CRF) in the absence of hormone feedback Endocrinology 90:1401–1403 (1972).
M. A. Slusher, Effect of chronic hypothalamic lesions on diurnal and stress corticosteroid levels, Am. J. Physiol 206:1161–1164 (1964).
G. P. Moberg, U. Scapagnini, J. DeGroot, and W. F. Ganong, Effect of sectioning the fornix on diurnal fluctuation in plasma corticosterone levels in the rat, Neuroendocrinology 7:11–15(1971).
D. T. Krieger and H. P. Krieger, Circadian variation of the plasma 17-hydroxycorticosteroids in central nervous disease, J. Clin. Endocrinol 26:929–940 (1966).
P. Chiefetz, N. Garrud, and J. F. Dingman, Effect of bilateral adrenalectomy and continuous light on the circadian rhythm of corticotropin in female rats, Endocrinology 82: 1117–1124(1967).
D. T. Krieger and F. Rizzo, Circadian periodicity of plasma 11-hydroxycorticosteroid levels in subjects with partial and absent light perception, Neuroendocrinology 8:165–179 (1971).
D. T. Krieger and H. P. Krieger, Effect of neo-and postnatal alteration of light environment on circadian periodicity of plasma cortiocosteroid levels (11-OHCS) in the rat, in “Proc. Internat. Union Physiol. Sci.” (1971), (Abst.).
D. N. Orth and D. P. Island, Light synchronization of the circadian rhythm in plasma Cortisol (17-OHCS) concentration in man, J. Clin. Endocrinol 29:479–486 (1969).
C. Lucke, N. Adelman, and S. M. Glick, The effect of elevated free fatty acids (FFA) on the sleep-induced human growth hormone peak, J. Clin. Endocrionol 35:407–412 (1972).
D. T. Krieger, J. Albin, S. Paget, and S. Glick, Failure of suppression of nocturnal growth hormone rise by acute corticosteroid administration, Horm. Metab. Dis (1972) (in press).
D. T. Krieger, in “Biorhythms and Human Reproduction,” Wiley, New York (1972).
J. W. Finkelstein, J. Kream, A. Ludan, and L. Hellman, Sulfation factor (somatomedin): An explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors, J. Clin. Endocrinol 35:13–17 (1972).
D. T. Krieger and S. Glick, Absent sleep peak of growth hormone release in blind subjects, J. Clin. Endocrinol 33:847–850 (1971).
E. D. Weitzman, M. Perlow, J. F. Sassin, D. Fukushima, B. Burack, and L. Hellman, Persistence of the twenty-four hour pattern of episodic cortisol secretion and growth hormone release in blind subjects, in “Proc. 97th Meeting Am. Neurol. Ass.,” p. 52 (1972).
C. Faiman and J. S. Winter, Diurnal cycles in plasma FSH, testosterone and cortisol in men, J. Clin. Endocrinol 33:186–192 (1971).
B. B. Saxena, H. Demura, H. M. Gandy, and R. E. Peterson, Radioimmunoassay of human follicle stimulating and luteinizing hormones in plasma, J. Clin. Endocrinol 28:519–534 (1968).
D. T. Krieger, R. Ossowski, M. Fogel, and W. Allen, Lack of circadian periodicity of human serum FSH and LH levels, J. Clin. Endocrinol 35:619–632 (1972).
R. T. Rubin, A. Kales, R. Adler, T. Fagan, and W. Odell, Gonadotropin secretion during sleep in normal adult men, Science 175:196–198 (1972).
M. A. Kirshner, M. B. Lipsett, and D. R. Collins, Plasma ketosteroids and testosterone in man: A study of the pituitary-testicular axis, J. Clin. Invest 44:657–665 (1965).
J. A. Resko and K. B. Eik-Nes, Diurnal testosterone levels in peripheral plasma of human male subjects, J. Clin. Endocrinol 26:573–576 (1966).
J. L. Evans, A. M. MacLean, A. A. Ismail, and D. Love, Circulating levels of plasma testosterone during sleep, Proc. Royal Soc. Med 64:841–842 (1971).
J. F. Sassin, A. G. Frantz, S. Kapen, and E. D. Weitzman, Human prolactin: 24 hour pattern with increased release during sleep, Science 75:1205–1207 (1972).
L. Vanhaelst, E. VanGauter, J. P. Degaute, and J. Goldstein, Circadian variations of serum thyrotropin levels in man, J. Clin. Endocrinol 35:479–482 (1972).
R. A. Gorski, in “Frontiers in Neuroendocrinology” (L. Martini and W. F. Ganong, eds.) pp. 237–290, Oxford University Press, New York (1971).
K. Milkovic and S. Milkovic, Functioning of the pituitary-adrenocortical axis in rats at and after birth, Endocrinology 73:535–539 (1963).
C. Allen and J. W. Kendall, Maturation of the circadian rhythm of plasma corticosterone in the rat, Endocrinology 80:926–930 (1967).
R. Ader, Early experiences accelerate maturation of the 24-hour adrenocortical rhythm, Science 163:1225–1226 (1969).
S. Schapiro, Neonatal cortisol administration: Effect on growth, the adrenal gland and pituitary-adrenal response to stress, Proc. Soc. Exptl. Biol. Med 120:771–774 (1965).
D. T. Krieger, Circadian corticosteroid periodicity: “Critical period” for abolition by neonatal corticosteroids, Science 178:1205–1207 (1972).
J. L. Bakke, N. Lawrence, and S. Robinson, Late effects of thyroxine injected into the hypothalamus of the neonatal rat, Neuroendocrinology 10:183–195 (1972).
H. G. Bauer, Endocrine and metabolic conditions related to pathology in the hypothalamus: A review, J. Neur. Ment. Dis 128:323–338 (1959).
R. W. Turkington, Secretion of prolactin by patients with hypothalamic tumors, J. Clin. Endocrinol 34:159–164 (1972).
M. Apostolakis, S. Kapetanakis, G. Lazos, and A. Madena-Pyrgaki, in “Lactogenic Hormones” (G. E. W. Wolstenhome and J. Knight, eds.) pp. 349–354, Churchill Livingston, Edinburgh (1972).
D. T. Krieger, S. Glick, A. Silverberg, and H. P. Krieger, A comparative study of endocrine tests in hypothalamic disease, J. Clin. Endocrinol 28:1589–1598 (1967).
D. T. Krieger, F. R. Ross, and H. P. Krieger, Response to dexamethasone suppression in central nervous system disease, J. Clin. Endocrinol 26:227–230 (1966).
S. A. Berson and R. Yalow, Immunoassay of ACTH in plasma, J. Clin. Invest 47:2725–2751 (1968).
D. T. Krieger, H. P. Kolodny, and H. P. Krieger, Metopirone studies in hypothalamicpituitary disease, J. Clin. Endocrinol 24:1169–1177 (1964).
P. Franchimont, in “Frontiers in Neuroendocrinology” (L. Martini and W. F. Ganong, eds.) pp. 331–359, Oxford University Press, New York (1971).
H. A. Selenkow, H. R. Tyler, D. D. Matson, and D. H. Nelson, Hypopituitarism due to hypothalamic sarcoidosis, Am. J. Med. Sci 238:456–463 (1959).
S. D. Gailani, A. L. Rogue, P. Band, and C. Ross, Hypopituitarism due to localized hypothalamic lesions, Arch. Int. Med 126:284–286 (1970).
F. A. Killeffer and W. E. Stern, Chronic effects of hypothalamic injury, Arch. Neurol 22:419–428 (1970).
L. Kahana, M. Lebovitz, W. Lusk, H. T. McPherson, E. T. Davidson, J. H. Oppenheimer, F. L. Engel, B. Woodhall, and G. Odon, Endocrine manifestations of intracranial extrasellar lesions, J. Clin. Endocrinol 21:304–324 (1962).
J. H. Oppenheimer, L. V. Fisher, and J. W. Jailer, Disturbance of the pituitary-adrenal interrelationship in diseases of the central nervous system, J. Clin. Endocrinol 21:1023–1036 (1961).
D. T. Krieger, The effect of diphenylhydantoin on pituitary-adrenal interrelations, J. Clin. Endocrinol 22:490–493 (1962).
V. H. Asfeldt and J. Buhl, Inhibitory effect of diphenylhydantoin on the feedback control of corticotrophin release, Acta Endocrinol 61:551–560 (1969).
M. T. Rabkin and A. G. Frantz, Hypopituitarism: A study of growth hormone and other endocrine functions, Ann. Int. Med 64:1197–1207 (1966).
J. Drewry, R. Unger, N. Kaplan, and J. Sanford, The pituitary-adrenal axis in encephalitis, in “Proc. 49th Meeting Endocrine Soc.” (1967) (abst. 126).
R. P. Sherwin, J. E. Grassi, and S. C. Sommers, Hamartomatous malformation of the posterolateral hypothalamus, Lab. Invest 11:89–97 (1962).
J. Gilroy and J. S. Meyer, in “An Introduction to Clinical Neuroendocrinology” (E. Bajusz, ed.) pp. 340–355, Karger, Basel (1967).
I. Gamstorp, B. Kjellman, and B. Palmgren, Diencephalic syndromes of infancy, J. Pediat 70:383–390 (1967).
G. T. Peake and W. H. Daughaday, Disturbance of pituitary function in central nervous system-disease, Med. Clin. N. Am 52:357–369 (1968).
J. F. Sotos, P. R. Dodge, D. Muirhead, J. D. Crawford, and N. B. Talbot, Cerebral gigantism in childhood, New Engl. J. Med 271:109–116 (1964).
B. Kjellman, Cerebral gigantism, Acta Paediat. Scand 54:603–609 (1965).
F. R. Ford, in “Diseases of the Nervous System,” p. 156, Thomas, Springfield, Ill. (1966).
R. A. Fefferman, G. Costin, and M. D. Kogut, Hypothalamic gigantism, Clin. Res 20:253 (1972).
G. E. Powell, J. A. Brasel, S. Raiti, and R. M. Blizzard, Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. II. Endocrinologic evaluation of the syndrome, New Engl. J. Med 276:1279–1283 (1967).
F. Kalimann, W. A. Schonfeld, and S. E. Barrera, The genetic aspects of primary eunuchoidism, Am. J. Ment. Defic 48:203–236 (1944).
S. Gauthier, La dyplasie olfacto-genetale (agenesis des lobes olfactifs avec absence de developpment gonadique a la puberte), Neuroveg 21:345–394 (1961).
H. M. Bruce, Pheromones, Brit. Med. Bull 26:10–13 (1970).
R. P. Michael and E. B. Keverne, Pheromones in the communication of sexual status in primates, Nature (London) 218:746–749 (1968).
J. I. Kitay and M. D. Altschule, “The Pineal Gland,” Harvard University Press, Cambridge, Mass. (1954).
R. J. Wurtman, J. Axelrod, and D. E. Kelly, “The Pineal,” Academic Press, New York (1968).
D. W. Cheesman and B. L. Fariss, Isolation and structure elucidation of a gonadotropin inhibiting peptide from the beef pineal gland, Clin. Res 17:167 (1970).
B. Landau, H. S. Schwartz, and L. J. Soffer, Presence of a gonadotropin-inhibiting factor in urine of young children, Metabolism 9:85–87 (1960).
J. F. Bing, J. M. Globus, and H. Simon, Pubertas praecox: A survey of the reported cases and verified anatomical findings, J. Mt. Sinai Hosp 4:935–965 (1964).
F. Albright, A. M. Butler, A. Hampton, and P. Smith, Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females, New Engl. J. Med 216:724–726 (1937).
J. J. Van Wyck and M. Grumbach, Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback. J. Pediat 57:416–435 (1960).
N. Liu, M. M. Grumbach, R. A. DeNapoli, and A. Morishima, Prevalence of electroencephalographic abnormalities in idiopathic precocious puberty and premature pubarche: Bearing on pathogenesis and neuroendocrine regulation of puberty, J. Clin. Endocrinol 25:1296–1308 (1965).
D. G. Barturka, B. A. Eskin, E. M. Smith, C. Dacou, and M. B. Dratman, Brain damage, hypertrichosis and polycystic ovaries, Am. J. Obstet. Gynecol 99:387–389 (1967).
I. A. Kamberi, R. S. Mical, and J. C. Porter, Prolactin inhibiting activity in hypophyseal stalk blood and elevation by dopamine, Experientia 26:1150–1151 (1970).
W. B. Malarky, L. S. Jacobs, and W. H. Daughaday, Levo-Dopa suppression of prolactin in nonpuerperal galactorrhea, New Engl. J. Med 285:1160–1163 (1971).
V. Marks, in “An Introduction to Clinical Neuroendocrinology” (E. Bajusz, ed.) pp. 328–339, Karger, Basel (1967).
T. Hart, Jr., N. Kase, and C. P. Kimball, Induction of ovulation and pregnancy in patients with anorexia nervosa, Am. J. Obstet. Gynecol 108:580–584 (1970).
J. Landon, F. C. Greenwood, T. C. B. Stamp, and V. Wynn, The plasma sugars, free fatty acid, cortisol, and growth hormone response to insulin and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa, J. Clin. Invest 45:437–449 (1966).
L. Shenkman, T. Mitsuma, A. Suphavai, and C. S. Hollander, Hypothalamic hypothyroidism, J. Am. Med. Ass 222:480–481 (1972).
C. R. Hamilton, L. C. Adams, and F. Maloof, Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma, New Engl. J. Med 283:1077–1080 (1970).
G. Faglia, C. Ferrari, V. Neri, P. Beck-Peccoz, B. Ambrosi, and F. Valentini, High plasma thyrotropin levels in two patients with pituitary tumor, Acta Endocrinol. Copen 69:649–658 (1972).
C. E. Emerson and R. D. Utiger, Hyperthyroidism and excessive thyrotropin secretion, New Engl. J. Med 287:328–333 (1972).
D. T. Krieger, The central nervous system and Cushing’s syndrome, Mount Sinai J. Med 39:416–428 (1972).
D. T. Krieger and S. Glick, Growth hormone and cortisol responsiveness in Cushing’s syndrome: Relation to a possible central nervous system etiology, Am. J. Med 52:25–40 (1972).
P. Heinbecker, Pathogenesis of Cushing’s syndrome, Medicine 23:225–247 (1944).
K. R. Crispell and W. Parson, Coexistence of Cushing’s syndrome and internal hydrocephalus produced by a cerebellar tumor, Am. J. Med 13:247–250 (1952).
S. M. Wolf, R. C. Adler, E. R. Buskirk, and R. H. Thompson, A syndrome of periodic hypothalamic discharge, Am. J. Med 36:956–967 (1964).
M. Seip, in “An Introduction to Clinical Neuroendocrinology” (E. Bajusz, ed.) pp. 414–427, Karger, Basel (1967).
W. Vale, G. Grant, J. Rivier, M. Monahan, M. Amors, R. Blackwell, R. Burgus, and R. Guillemin, Synthetic Polypeptide antagonists of the hypothalamus luteinizing releasing factor, Science 176:933–934 (1972).
D. T. Krieger, The hypothalamus and Hosp. Practice neuroendoerinology. 6:87–99 (1971).
D. T. Krieger, Hosp. Practice (6:127–138 1971).
P. D. Maclean, Am. J. Med 25:611–626 (1958).
E. Scharrer, Arch. Anat. Microscop. Morphol. Exptl 54:364–365 (1965).
J. P. Schadé, in “Pituitary, Adrenal, and The Brain.” Progress in Brain Research (D. de Wied and J. A. W. M. Weijaen, eds.) pp. 2–10, Elsevier, Amsterdam (1970).
J. C. Porter, R. C. Mical, I. Kamberi, and Y. R. Grazia, Endocrinology 87:197–200 (1970).
W. Vale, P. Brazeau, C. Rivier. J. Rivier, G. Grant, R. Burgus, and R. Guillemin, Biological activities of somatostatin, Program 55th Annual Meeting Endocrine Society, A-118 (1973).
R. M. MacLeod and J. E. Lehmeyer, Pituitary gland alpha-adrenergic receptors and their function in prolactin secretion, Program 55th Annual Meeting Endocrine Society, A-50 (1973).
E. A. Zimmerman, K. C. Hsu, L. Cote, M. Tannenbaum, L. S. Freedman, M. Roffman, and M. Goldstein, Studies of dopamine-B-hydroxylase in bovine pituitary and adrenal glands using an immunoperoxidase technique, Fed. Proc 32:296 (1973).
F. J. Karsch, D. J. Dierschke, and E. Knobil, Sexual differentiation of pituitary function: apparent difference between primates and rodents, Science 179:484–486 (1973).
G. Tolis, E. del Pozo, and M. S. Goldstein, Dopamine and ergocryptine effects on hyperprolactinemic states, Program 55th Annual Meeting Endocrine Society, A-50 (1973).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Plenum Press, New York
About this chapter
Cite this chapter
Krieger, D.T. (1973). Pathophysiology of Central Nervous System Regulation of Anterior Pituitary Function. In: Gaull, G.E. (eds) Biology of Brain Dysfunction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2670-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2670-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2672-4
Online ISBN: 978-1-4684-2670-0
eBook Packages: Springer Book Archive